Document:

Amendment No.2 to Asset Purchase Agreement

 EXHIBIT 10.1 
 February 3, 2011 
 Hologic, Inc. 
 35 Crosby Drive 
 Bedford, MA 01730 
 Attn: Robert Cascella 
 Dear Robert: 

Pursuant to that certain Asset Purchase Agreement by and among K-V Pharmaceutical Company, a Delaware corporation
(“Acquiror”), Cytyc Prenatal Products Corp., a Delaware corporation (“Cytyc”), and Hologic, Inc., a Delaware corporation (“Seller”), dated as of January 16, 2008 and as
amended by a letter agreement dated January 8, 2010 (“Amendment No. 1”) (as amended by Amendment No. 1, the “Amended Agreement”), the Acquiror and the Seller are entering
into this amendment (this “Amendment No. 2”) to amend certain provisions of the Amended Agreement as of the date hereof. In consideration of the terms set forth in this Amendment No. 2, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the Acquiror and the Seller agree as follows: 
 1.
The following definitions in Section 1.1 of the Amended Agreement are amended and restated in their entirety as follows: 
 “Additional Purchase Price Amount” means the amounts payable pursuant to Sections 4.2(b)(ii)-(iii)(A) below in the event the Acquiror notifies Seller of its election to
chose Payment Schedule 1, and means the amounts payable pursuant to Sections 4.2(b)(ii)-(iii)(B) below in the event the Acquiror notifies Seller of its election to chose Payment Schedule 2. 

2. Section 4.2(b) of the Amended Agreement is amended and restated in its entirety as follows: 

“(b) Subject to the terms and conditions of this Agreement: 

(i) On the Transfer Date, the Acquiror shall pay to the Seller $12,500,000 (the “First Additional Purchase
Price Payment”). 
 (ii) On the date that is twelve (12) months after the Gestiva NDA Approval
Date, the Acquiror shall pay to the Seller $12,500,000, provided that the Transfer Date has already occurred. 

(iii) Prior to the date that is eighteen (18) months after the Gestiva NDA Approval Date, the Acquiror shall provide
written notice to the Seller as of its intention to pay the remainder of the Purchase Price in accordance with Payment Schedule 1 set forth in subsection (iii)(A) below or Payment Schedule 2 set forth in subsection (iii)(B) below and Acquiror will
thereafter be responsible for paying the remainder of the 

 
Purchase Price in accordance with the payment schedule identified in such notice. If no such election is made by the Acquiror prior to the date that is eighteen (18) months after the Gestiva
NDA Approval Date, the Acquiror will be deemed to have selected Payment Schedule 1. 
  

	 	(A)	Payment Schedule 1 

 (1) On the date that is eighteen (18) months after the Gestiva NDA Approval Date, the Acquiror shall pay to the Seller $45,000,000, plus the Royalty Amount for the period beginning on the date that
is twelve (12) months after the Gestiva NDA Approval Date and ending on the date that is eighteen (18) months after the Gestiva NDA Approval Date, provided that the Transfer Date has already occurred. 

(2) On the date that is twenty one (21) months after the Gestiva NDA Approval Date, the Acquiror shall pay to the
Seller $20,000,000, provided that the Transfer Date has already occurred. 
 (3) On the date that is twenty four
(24) months after the Gestiva NDA Approval Date, the Acquiror shall pay to the Seller $20,000,000, plus, any amount due pursuant to subsection (iii)(A)(2) and previously unpaid, provided that the Transfer Date has already occurred. 

(4) On the date that is twenty seven (27) months after the Gestiva NDA Approval Date, the Acquiror shall pay to the
Seller $10,000,000 plus, any amount due pursuant to subsection (iii)(A)(2) or (iii)(A)(3) and previously unpaid, provided that the Transfer Date has already occurred. 

(5) Notwithstanding the foregoing, if the Acquirior makes the payment of $45,000,000 owed to the Seller pursuant to
subsection (iii)(A)(1) at any time prior to the date that is eighteen (18) months after the Gestiva NDA Approval Date (the date of such $45,000,000 payment being referred to herein as the “$45 Million Payment Date”), the
Royalty Amount required to be paid pursuant to subsection (iii)(A)(1) shall be calculated during the period beginning on the date that is twelve (12) months after the Gestiva NDA Approval Date and ending on the $45 Million Payment Date, which
Royalty Amount shall be paid within ten Business Days of such $45 Million Payment Date, and the payments required to be made by the Acquiror to the Seller pursuant to subsections (iii)(A)(2), (iii)(A)(3) and (iii)(A)(4) shall thereafter be due from
the Acquiror to the Seller at three month intervals following the $45 Million Payment Date. 
 (6) In the event
that Acquiror fails to make any of the payments required to be made pursuant to subsection (iii)(A)(2), 

  
 2 

 
(iii)(A)(3), (iii)(A)(4) or (iii)(A)(5) in full when due (a “Quarterly Payment Default”), the Acquiror shall pay to the Seller the Royalty Amount for the delinquent
quarterly payment period (less any Accrued Royalty Amount previously paid with respect to such delinquent quarterly period) within ten Business Days of such delinquent quarterly due date and such failure shall not be considered a Payment Default for
purposes of Section 12.4 hereof if such Royalty Amount is so paid. Following any Quarterly Payment Default, the Royalty Amount shall continue to accrue during subsequent quarters until Acquiror pays in full any delinquent payment(s)
under subsections (iii)(A)(2), (iii)(A)(3), (iii)(A)(4) and/or (iii)(A)(5) as the case may be (the “Accrued Royalty Amount”), with such Accrued Royalty Amount to be paid within ten Business Days after payment in full of any
delinquent payment(s). 
  

	 	(B)	Payment Schedule 2 

 (1) On the date that is eighteen (18) months after the Gestiva NDA Approval Date, the Acquiror shall pay to the Seller $7,307,692.30, plus the Royalty Amount for the period beginning on the date that
is twelve (12) months after the Gestiva NDA Approval Date and ending on the date that is eighteen (18) months after the Gestiva NDA Approval Date, provided that the Transfer Date has already occurred. 

(2) On each of the next twelve successive monthly anniversaries of the Gestiva NDA Approval Date occurring after the date
set forth in subsection (B)(1) above, the Acquiror shall pay to the Seller $7,307,692.30, provided that the Transfer Date has already occurred. 
 (3) Within ten Business Days of the date that is twenty four (24) months after the Gestiva NDA Approval Date, the Acquiror shall pay to the Seller the Royalty Amount for the period beginning on the
date that is eighteen (18) months after the Gestiva NDA Approval Date and ending on the date that is twenty four (24) months after the Gestiva NDA Approval Date. 

(4) Within ten Business Days of the date that is thirty (30) months after the Gestiva NDA Approval Date, the
Acquiror shall pay to the Seller the Royalty Amount for the period beginning on the day immediately following the date that is twenty four (24) months after the Gestiva NDA Approval Date and ending on the date that is thirty (30) months
after the Gestiva NDA Approval Date. 
 For purposes of this Section 4.2(b), the term “Royalty
Amount” shall mean an amount equal to 5% of Net Sales booked by the Acquiror and any Affiliates of the Acquiror during the applicable period from the sale of Gestiva. For purposes

  
 3 

 
hereof, “Net Sales” shall mean the gross amount invoiced by Acquiror or its Affiliates for sales of Gestiva to independent third parties, less, and only to the extent such
items were actually incurred by the Acquiror or its Affiliates as a result of the sale of Gestiva, (a) trade, quantity and/or cash discounts, incentive payments or rebates actually booked, taken or allowed; (b) discounts, refunds, rebates,
chargebacks, retroactive price adjustments; (c) actual returns and allowances, (d) freight charges, shipping, delivery, insurance and packing charges, and (e) taxes (other than income taxes, but including excise, value added, sales
and use taxes), duties or other governmental charges levied on the sale or measured by the invoiced amount, absorbed by the Acquiror or its Affiliates. 
 The Acquiror shall not, nor shall it permit or cause any Affiliate to, directly or indirectly shift the sales of Gestiva, or shift revenue of any kind derived therefrom, from one period to another or
otherwise manipulate the sale of Gestiva, or manipulate the revenue of any kind derived therefrom, in a manner intended to avoid the payment of any portion of the Royalty Amount during any period within which the Royalty Amount is payable by the
Acquiror to the Seller. 
 The Acquiror agrees to keep all usual and proper records and books of account and all usual and proper
entries relating to the sale of Gestiva for a period of four years following the date of the Gestiva NDA Approval Date. The Seller may cause an audit and/or inspection to be made, with at least five Business Days prior written notice to the
Acquiror, of the applicable Acquiror records and facilities in order to verify the Royalty Amount with respect to any applicable period within which the Royalty Amount is payable by the Acquiror to the Seller. Any such audit will be conducted at the
Acquiror’s facilities during the regular business hours of the Acquiror without disruption to the Acquiror’s business. The Acquiror agrees to provide the Seller’s audit team with access to the relevant records and facilities of the
Acquiror. Any such audit will be paid for by the Seller, provided however, that in the event that such audit uncovers a shortfall in the Royalty Amount with respect to the applicable period that exceeds 10% or more of the Royalty Amount paid to the
Seller during the applicable audited period, the Acquiror shall promptly upon demand reimburse the Seller for the reasonable costs of such audit. 
 Notwithstanding anything to the contrary contained herein, the Acquiror may make any of the foregoing payments on or before their due dates. The date on which the Acquiror makes the final payment
contemplated by Section 4.2(b)(iii)(A) above or Section 4.2(b)(iii)(B) above, as applicable, is the “Final Payment Date,” and the Royalty Amount shall not be computed on any Net Sales
occurring after the Final Payment Date. 
 3. Section 12.4(a) of the Amended Agreement is amended and restated in
its entirety as follows: 
 “Section 12.4 Retransfer of Assets from the Acquiror to the Seller. 

  
 4 

 (a) If, prior to the Final Payment Date, the Acquiror breaches its
obligation to pay (i) any portion of the Additional Purchase Price Amount (other than the First Additional Purchase Price Payment or as otherwise provided in Section 4.2(b)(iii)(A)) then due, and such breach has not been cured within a
period of ten (10) days following the Seller’s written notice of such breach to the Acquiror, or (ii) any undisputed Reimbursable Expenses, and such breach has not been cured within a period of thirty (30) days following the
Seller’s written notice of such breach to the Acquiror (a “Payment Default”), then for a period of sixty (60) days the Seller may notify the Acquiror in writing that Seller is electing to exercise its remedies
pursuant to this Section 12.4,” provided, however, that any dispute regarding Royalty Amounts shall not be deemed a Payment Default until thirty (30) days after such amount is finally determined by audit or in accordance with the
dispute resolution procedures set forth in this Agreement. 
 4. Section 12.5 of the Amended Agreement is amended
and restated in its entirety as follows: 
 “Section 12.5 Power of Attorney. Subject to the remaining
terms hereof, by execution of this Agreement, from and after the occurrence of any Payment Default, Acquiror hereby constitutes and appoints Seller as its true and lawful representative and attorney-in-fact, in its name, place and stead, to make,
execute, sign, acknowledge and deliver or file all instruments, documents and certificates that may be required to effectuate the transfer of the Retransferred Assets as contemplated by Section 12.4 and the transactions contemplated
thereby. The foregoing grant of authority, which may only be exercised by the Seller after the occurrence of any Payment Default, is a special power of attorney coupled with an interest in favor of Seller and as such shall be irrevocable prior to
the Final Payment Date and shall survive the merger, dissolution or other termination of the existence of Acquiror. The foregoing grant of authority shall automatically expire and be of no further force and effect on the date that is 120 days
following the Final Payment Date. 
 5. The Amended Agreement as amended by this Amendment is hereby ratified and confirmed. The
terms of this Amendment No. 2 shall govern and control in the event of any conflict between the terms of this Amendment and the terms of (a) any correspondence, discussions or other oral arrangements, agreements or understandings between
the parties regarding the subject matter contained herein, and/or (b) the Amended Agreement. On a go-forward basis, references to the “Agreement” shall mean references to the Amended Agreement, as modified by this
Amendment. 
 6. The provisions of ARTICLE XIII of the Original Agreement shall apply to this Amendment, mutatis
mutandis, as if such provisions were set forth herein (with such non-substantive modifications to such provisions as are necessary to effectuate the terms of this Amendment, without varying the substantive terms hereof). 

7. Capitalized terms used and not otherwise defined herein have the meanings assigned to them in the Original Agreement. This Amendment
may be executed in one or more counterparts, each of which will be deemed an original copy of this Amendment and all of which, when taken together, will be deemed to constitute one and the same agreement. 

  
 5 

 Sincerely yours, 
  

			
	ACQUIROR:
	 K-V PHARMACEUTICAL COMPANY,
 a Delaware corporation

		
	By:	 	 /s/ Gregory J. Divis, Jr.

		
	Name:	 	Gregory J. Divis, Jr.
		
	Title:	 	President and Chief Executive Officer

 Acknowledged and
agreed as of the date first 
 written above: 
 SELLER: 
 HOLOGIC, INC., 
 a Delaware corporation (on its own behalf and as the successor to Cytyc Prenatal Products Corp.) 
  

			
	By:	 	 /s/ Robert Cascella

		
	Name:	 	Robert Cascella
		
	Title:	 	Chief Executive OfficerOffer Letter - Edward A. Henrich

 Exhibit 10.7 
 [Responsys Logo] 
 March 21, 2007 
 Ed Henrich 
 Via Email 
 Dear Ed: 
 It gives me great pleasure on behalf of Responsys, Inc. to offer you employment as Vice
President of Strategic Services on the following terms: 
  

	1.	Position. The Company will employ you in a full-time position. Your title will be Vice President of Strategic Services and you will report to the Chief Customer
Officer. By signing this letter agreement, you confirm to the Company that you have no contractual commitments or other legal obligations that would prohibit you from performing your duties for the Company. You agree that your first day of
employment shall be April 2, 2007. 

  

	2.	Compensation. The Company will pay you a starling salary at the rate of $15,000 per month, payable in accordance with the Company’s standard payroll
schedule. You will also be eligible for an Annual Target Bonus in the amount of $50,000 which will be based upon the attainment of specific revenue goals and objectives that will be assigned to you shortly after your start date. In addition, you
will be eligible for a Stretch Bonus in the amount of $50,000 based on the attainment of revenue goals in excess of current targets. See attached Exhibit F for details. You are also eligible to receive a 2% referral commission, on first twelve
months revenue, from new business closed before December 31, 2007 for companies named in Exhibit E. Any payments relating to these bonuses will be governed by the terms and conditions of the Responsys Incentive Compensation Plan. In
addition, if you sign and return the offer before Wednesday March 28, 2007, we will pay you a signing bonus in the amount of $20,000. Payment for the signing bonus will be made via the next regular company payroll cycle following 60 days
employment. 

  

	3.	Employee Benefits. As a regular employee of the Company, you will be eligible to participate in a number of Company-sponsored benefits. In addition, you will be
entitled to paid vacation in accordance with the Company’s standard vacation policy, with the exception that your vacation accrual rate shall be 6.66 hours per pay period, effective immediately. 

 

	4.	Stock Options. Subject to the approval of the Company’s Board of Directors or its Compensation Committee, you will be granted an option to purchase 350,000
shares of the Company’s Common Stock. The exercise price per share will be equal to the fair market value per share on the date the option is granted or on your first day of employment, whichever is later. The option will be subject to the
terms and conditions applicable to options granted under the Company’s 1999 Stock Plan (the “Plan”), as described in the Plan and the applicable Stock Option Agreement. The option will be immediately exercisable, but the purchased
shares will be subject to repurchase by the Company at the exercise price in the event that your service terminates for any reason before you vest in the shares. You will vest in 25% of the option shares after 12 months of continuous service, and
the balance will vest in equal monthly installments over the next 36 months of continuous service, as described in the applicable Stock Option Agreement. 

 Change in Control. In the event of a sale or merger of the company (other than in
connection with a reincorporation) which results in more than a 50% change of control of the outstanding shares, 25% of your unvested shares will accelerate if within 12 months following a change of control, there is an Involuntary Termination of
your employment. The provisions contained in this section are not exclusive of the provisions and benefits provided elsewhere in this agreement. “Involuntary Termination” is defined as either (a) involuntary discharge by the Company
for reasons other than Cause or (b) your voluntary resignation because the annual rate of your base salary or bonus was reduced by the Company without your written consent, your duties were substantially reduced in scope, or because you were
required to relocate or report to a location more than 35 miles from the Company’s present location, without your written consent. 
  

	5.	Proprietary Information and Inventions Agreement. Like all Company employees, you will be required, as a condition to your employment with the Company, to sign
the Company’s standard Proprietary Information and Inventions Agreement, a copy of which is attached hereto as Exhibit A. 

  

	6.	Employment Relationship. Employment with the Company is for no specific period of time. Your employment with the Company will be “at will,” meaning
that either you or the Company may terminate your employment at any time and for any reason, with or without cause. Any contrary representations that may have been made to you are superseded by this offer. This is the full and complete
agreement between you and the Company on this term. Although your job duties, title, compensation and benefits, as well as the Company’s personnel policies and procedures, may change from time to time, the “at will” nature of
your employment may only be changed in an express written agreement signed by you and the Chief Executive Officer of the Company. 

  

	7.	Non Compete. By accepting Responsys’ offer of employment, you represent and warrant that you are not obligated to another entity or company under an
agreement of non-competition or any other agreement that, in any way, could interfere with your employment by Responsys. Further, you represent and agree that you have not removed any non-public materials, information, data or other
confidential or proprietary information from the premises of your previous employer(s). Under no circumstances will you use any such materials, information or data in connection with your employment at Responsys. 

 

	8.	Outside Activities. While you render services to the Company, you will not assist any person or entity in competing with the Company, in preparing to
compete with the Company or in hiring any employees or consultants of the Company. While you render services to the Company, you agree that you will not engage in any other employment, consulting or other business activity without the written
consent of the Company. 

 Responsys grants an exception to this rule regarding your continued participation on the
Board of Directors for Vertical Response. Responsys also grants an exception to this rule regarding continued low activity involvement in your two current businesses Henrich Enterprises, Inc. and DragonVista LLC. Your continued work in those
businesses must not interfere with your responsibilities’ to Responsys and must not use Responsys equipment, supplies, facilities, or trade secret information. 
  

	9.	Withholding Taxes. All forms of compensation referred to in this letter agreement are subject to reduction to reflect applicable withholding and payroll taxes
and other deductions required by law. 

  

	10.	Entire Agreement. This letter agreement supersedes and replaces any prior understandings or agreements, whether oral or written, between you and the Company
regarding the subject matter described in this letter agreement. 

	11.	Arbitration. You and the Company agree to waive any rights to a trial before a judge and a jury and agree to arbitrate before a neutral arbitrator any and all
claims or disputes arising out of this letter agreement and any and all claims arising from or relating to your employment with the Company, including (but not limited to) claims against any current or former director or agent of the Company, claims
or wrongful termination, retaliation, discrimination, harassment, breach of contract, breach of covenant of good fait and fair dealing, invasion of privacy, fraud, misrepresentation, constructive discharge or failure to provide a leave of absence,
or claims regarding commissions, stock options or bonuses, infliction of emotional distress or unfair business practices. 

 The arbitrator’s decision must be written and must include the findings of fact and Law that support that decision. The arbitrator’s decision will be final and binding on both parties, except to
the extent applicable law allows for judicial review of arbitration awards. The arbitrator may award any remedies that would otherwise be available to parties if they were to bring the dispute in court. The arbitration will be conducted with the
National Rules for the Resolution of Employment Disputes of the American Arbitration Association; provided, however that the arbitrator must allow the discovery authorized by the California Arbitration Act or the discovery that the arbitrator deems
necessary for the parties to vindicate their respective claims or defenses. The arbitration will take place in Santa Clara County or, at your option, the county in which you primarily worked with the Company at the time when the arbitral dispute or
claim first arose. 
 You and the Company will share the cost of the arbitration equally, except that the Company will bear the
cost of the arbitrator’s fee and any other type of expense or cost that you would not be required to bear if you were to bring the dispute or claim in court. Both the Company and you will be responsible for their own attorney’s fees, and
the arbitrator may not award attorney’s fees unless a statute or contract at issue specifically authorizes such an award. 

The foregoing, not withstanding, this arbitration provision does not apply to (a) workers compensation or unemployment insurance
claims or (b) claims concerning the ownership, validity, infringement, misappropriation, disclosure, misuse or enforceability of any confidential information, patent right, copyright, mask work, trademark, or any other trade secret or
intellectual property held or sought by either you or the Company (whether or not arising under the Proprietary Information and Inventions Agreement between you and the Company). 

If an arbitrator or court of competent jurisdiction (the “Neutral”) determines that any provision of this arbitration provision
is illegal or unenforceable, then the Neutral will modify or replace the language of this arbitration provision with a valid and enforceable provision, but only to the minimum extend necessary to render this arbitration provision legal and
enforceable. 
 Ed, we hope that you find the foregoing terms acceptable. You may indicate your agreement with these terms and accept this
offer by signing and dating a printed copy of this letter agreement and the attached Proprietary Information and Inventions Agreement and returning them to me. This offer, if not accepted, will expire at the close of business on Wednesday,
March 28, 2007. As required by law, your employment with the Company is contingent upon your providing legal proof of your identity and authorization to work in the United States. You understand and agree that this offer of employment is
contingent upon Responsys’ receipt of a satisfactory security clearance based upon the results of a criminal background investigation. By signing this letter, you agree to allow Responsys to obtain a limited background investigation.

 
	
	 Sincerely,
  

	 /s/ Dan Springer
  

	 Dan Springer
 Chief Executive
Officer

 I have read and accept this employment offer: 

 

					
	Date:	  	 3/27/07
	  	
	Employee Signature:	  	 /s/ Edward Henrich
	  	
		  	 Edward Henrich
	  	
		
	Attachments:	  	Employment, Confidential Information & Invention Assignment Agreement
		
		  	Exhibit A: List Of Prior Inventions & Original Works of Authorship
		
		  	Exhibit B: California Labor Code Section 2870 Employment Agreements; Assignment of Rights
		
		  	Exhibit C: Responsys, Inc. Termination Certification
		
		  	Exhibit D: Responsys, Inc. Conflict of Interest Guidelines
		
		  	Exhibit E: Companies qualifying for referral bonus

 [Responsys Logo] 
 EMPLOYMENT, CONFIDENTIAL INFORMATION & 
 INVENTION ASSIGNMENT
AGREEMENT 
 As a condition of my employment with Responsys, Inc., its subsidiaries, affiliates, successors or assigns (together the
“Company”), and in consideration of my employment with the Company and my receipt of the compensation now and hereafter paid to me by Company, I, Ed Henrich , agree to the following: 

 

	1.	At-Will Employment. I understand and acknowledge that my employment with the Company is for an unspecified duration and constitutes “at-will”
employment. I acknowledge that this employment relationship may be terminated at any time, with or without good cause or for any or no cause, at the option either of the Company or me. 

 

	2.	Confidential Information. 

(a) Company Information. I agree at all times during the term of my employment and thereafter, to hold in strictest confidence, and
not to use, except for the benefit of the Company, or to disclose to any person, firm or corporation without written authorization of the Board of Directors of the Company, any Confidential Information of the Company. I understand that
“Confidential Information” means any Company proprietary information, technical data, trade secrets or know-how, including, but not Limited to, research, product plans, products, services, customer lists and customers (including, but
not Limited to, customers of the Company on whom I called or with whom I became acquainted during the term of my employment), markets, software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, hardware
configuration information, marketing, finances or other business information disclosed to me by the Company either directly or indirectly in writing, orally or by drawings or observation of parts or equipment. I further understand that Confidential
Information does not include any of the foregoing items which has become publicly known and made generally available through no wrongful act of mine or of others who were under confidentiality obligations as to the item or items involved.

 (b) Former Employer Information. I agree that I will not, during my employment with the Company, improperly use or disclose
any proprietary information or trade secrets of any former or concurrent employer or other person or entity and that I will not bring onto the premises of the Company any unpublished document or proprietary information belonging to any such
employer, person or entity unless consented to in writing by such employer, person or entity. 
 (c) Third Party Information. I
recognize that the Company has received and in the future will receive from third parties their confidential or proprietary information subject to a duty on the Company’s part to maintain the confidentiality of such information and to use it
only for certain Limited purposes. I agree to hold all such confidential or proprietary information in the strictest confidence and not to disclose it to any person, firm or corporation or to use it except as necessary in carrying out my work
for the Company consistent with the Company’s agreement with such third party. 
  

	3.	Inventions. 

 (a)
Inventions Retained and Licensed. I have attached hereto, as Exhibit A, a list describing all inventions, original works of authorship, developments, improvements, and trade secrets which were made by me prior to my employment with the Company
(collectively referred to as “Prior Inventions”), which belong to me, which relate to the Company’s proposed business, products or research and development, and which are not assigned to the Company hereunder; or, if no such fist
is attached, I represent that there are no such Prior Inventions. If in the course of my employment with the Company, I incorporate into a Company product, process or machine a Prior Invention owned by me or in which I have an interest,
the Company is hereby granted and shall have a nonexclusive, royalty-free, irrevocable, perpetual, worldwide license to make, have made, modify, use and sell such Prior Invention as part of or in connection with such product, process or
machine. 

  
 5 

 (b) Assignment of Inventions. I agree that I will promptly make full written disclosure to
the Company, will hold in trust for the sole right and benefit of the Company, and hereby assign to the Company, or its designee, all my right, title, and interest in and to (i) any and all inventions, original works of authorship,
developments, concepts, improvements or trade secrets, whether or not patentable or registrable under copyright or similar laws, that I may solely or jointly conceive or develop or reduce to practice, or cause to be conceived or developed or reduced
to practice, during the period of time I am in the employ of the Company, and (ii) do hereby so assign any and all proprietary information, trade secrets that underlie, are summarized, embodied or described in, the Company’s Business Plan,
a copy of which is incorporated herein by reference and made a part hereof, and all copyrights, whether or not registered, therefore, all trade secrets and/or proprietary information and all other intellectual property rights, no matter how
described or denominated, described, contained or reflected therein or related thereto that I have conceived, invented, created or reduced to practice (either prior to the date hereof or at anytime during the term of my employment) in
furtherance thereof (collectively referred to as “Inventions”), except as provided in Section 3(f) below. I further acknowledge that aft original works of authorship that are made by me (solely or jointly with others) within the
scope of and during the period of my employment with the Company and which are protectible by copyright are “works made for hire,” as that term is defined in the United States Copyright Act. 

(c) Inventions Assigned to the United States. I agree to assign to the United States government all my right, title, and interest in and
to any and all Inventions whenever such full title is required to be in the United States by a contract between the Company and the United States or any of its agencies. 
 (d) Maintenance of Records. I agree to keep and maintain adequate and current written records of all Inventions made by me (solely or jointly with others) during the term of my employment with the
Company. The records will be in the form of notes, sketches, drawings, and any other format that may be specified by the Company. The records will be available to and remain the sole property of the Company at all times. 

(e) Patent and Copyright Registrations. I agree to assist the Company, or its designee, at the Company’s expense, in every proper way
to secure the Company’s rights in the Inventions and any copyrights, patents, mask work rights or other intellectual property rights relating thereto in any and all countries, including the disclosure to the Company of all pertinent
information and data with respect thereto, the execution of all applications, specifications, oaths, assignments and all other instruments which the Company shall deem necessary in order to apply for and obtain such rights and in order to assign and
convey to the Company, its successors, assigns, and nominees the sole and exclusive rights, title and interest in and to such Inventions, and any copyrights, patents, mask work rights or other intellectual property rights relating thereto. I further
agree that my obligation to execute or cause to be executed, when it is in my power to do so, any such instrument or papers shall continue after the termination of this Agreement. If the Company is unable because of my mental or physical
incapacity or for any other reason to secure my signature to apply for or to pursue any application for any United States or foreign patents or copyright registrations covering Inventions or original works of authorship assigned to the Company
as above, then f hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as my agent and attorney in fact, to act for and in my behalf and stead to execute and file any such applications and to do all other
lawfully permitted acts to further the prosecution and issuance of letters patent or copyright registrations thereon with the same legal force and effect as if executed by me. 
 (f) Exception to Assignments. I understand that the provisions of this Agreement requiring assignment of Inventions to the Company do not apply to any invention which qualifies fully under the provisions
of California Labor Code Section 2870 (attached hereto as Exhibit B). I will advise the Company promptly in writing of any inventions that I believe meet the criteria in California Labor Code Section 2870 and not otherwise disclosed on
Exhibit A. 
  

	4.	Conflicting Employment. I agree that, during the term of my employment with the Company, I will not engage in any other employment, occupation, consulting or
other business activity directly related to the business in which the Company is now involved or becomes involved during the term of my employment, nor will I engage in any other activities that conflict with my obligations to the Company.

  
 6 

	5.	Returning Company Documents. I agree that, at the time of leaving the employ of the Company, I will deliver to the Company (and will not keep in my possession,
recreate or deliver to anyone else) any and all devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings blueprints, sketches, materials, equipment, other documents or property, or reproductions of any
aforementioned items developed by me pursuant to my employment with the Company or otherwise belonging to the Company, its successors or assigns. In the event of the termination of my employment, I agree to sign and deliver the “Termination
Certification” attached hereto as Exhibit C. 

  

	6.	Notification of New Employer. In the event that I leave the employ of the Company, I hereby grant consent to notification by the Company to my new employer about
my rights and obligations under this Agreement. 

  

	7.	Solicitation of Employees. I agree that for a period of twelve (12) months immediately following the termination of my relationship with the Company for any
reason, whether with or without cause, I shall not either directly or indirectly solicit, induce, recruit or encourage any of the Company’s employees to leave their employment, or take away such employees, or attempt to solicit, induce,
recruit, encourage or take away employees of the Company, either for myself or for any other person or entity. 

  

	8.	Conflict of interest Guidelines. I agree to diligently adhere to the Conflict of Interest Guidelines attached as Exhibit D hereto. 

 

	9.	Representations. I agree to execute any proper oath or verify any proper document required to carry out the terms of this Agreement. I represent that my
performance of all the terms of this Agreement will not breach any agreement to keep in confidence proprietary information acquired by me in confidence or in trust prior to my employment by the Company. I have not entered into, and I agree I will
not enter into, any oral or written agreement in conflict herewith. 

  

	10.	Arbitration and Equitable Relief. 

 (a) Arbitration. Except as provided in Section 10(b) below, I agree that any dispute or controversy arising out of or relating to any interpretation, construction, performance or breach of this
Agreement, shall be settled by arbitration to be held in San Mateo County, California, in accordance with the rules then in effect of the American Arbitration Association. The arbitrator may grant injunctions or other relief in such dispute or
controversy. The decision of the arbitrator shall be final, conclusive and binding on the parties to the arbitration. Judgment may be entered on the arbitrator’s decision in any court having jurisdiction. The Company and I shall each pay
one-half of the costs and expenses of such arbitration, and each of us shall separately pay our counsel fees and expenses. 
 (b)
Equitable Remedies. I agree that it would be impossible or inadequate to measure and calculate the Company’s damages from any breach of the covenants set forth in Sections 2, 3, and 5 herein. Accordingly, I agree that if I breach any of such
Sections, the Company will have available, in addition to any other right or remedy available, the right to obtain an injunction from a court of competent jurisdiction restraining such breach or threatened breach and to specific performance of any
such provision of this Agreement. I further agree that no bond or other security shall be required in obtaining such equitable relief and I hereby consent to the issuance of such injunction and to the ordering of specific performance. 

 

	11.	General Provisions. 

 (a)
Governing Law; Consent to Personal Jurisdiction. This Agreement will be governed by the laws of the State of California, without reference to choice of laws or conflict of laws principles. I hereby expressly consent to the personal jurisdiction of
the state and federal courts located in California for any lawsuit filed there against me by the Company arising from or relating to this Agreement. 
 (b) Entire Agreement. This Agreement sets forth the entire agreement and understanding between the Company and me relating to the subject matter herein and merges all prior discussions between us. No
modification of or amendment to this Agreement, nor any waiver of any rights under this agreement, will be effective unless in writing signed by the party to be charged. Any subsequent change or changes in my duties, salary or compensation will
not affect the validity or scope of this Agreement. 

  
 7 

 (c) Severability. If one or more of the provisions in this Agreement are deemed void by law,
then the remaining provisions will continue in full force and effect. 
 (d) Successors and Assigns. This Agreement will be
binding upon my heirs, executors, administrators and other legal representatives and will be for the benefit of the Company, its successors, and its assigns. 
 IN WITNESS WHEREOF, I execute this Agreement as of the date written below. 
  

			
	Date:	 	3/27/07
	Employee Signature:	 	/s/ Edward Henrich
		 	Ed Henrich
		
	Witness	 	 

  
 8 

 EXHIBIT A 
 LIST OF PRIOR INVENTIONS AND ORIGINAL WORKS OF AUTHORSHIP 
  

					
	 Title
	  	 Date
	  	 Identifying Number & Brief
Description

	Monitoring of Competitor Websites and Email Marketing	  	Prior to 3/26/2007	  	Service provides for delivery of information on websites and email marketing programs for competitive intelligence. Information is delivered to customers via email, and also
available as an online archive. (Part of DragonVista LLC.)
			
	Archive ClickMaps and other Web Based Reporting	  	Prior to 3/26/2007	  	Service provides for capturing and storing click maps, since most web analytics tools no longer work once a website has changed. Also provide screen capture of other reports
for training purposes.
			
	Various Excel based internal marketing dashboards	  	Prior to 3/26/2007	  	Excel based dashboards for internet marketing analytics developed at Henrich Enterprises, Inc.
			
	IP-based Firmagraphics	  	Prior to 3/26/2007	  	 System for building a database of IP addresses which have associated with them business name, location and firmographics (firm size,
SIC code, industry, etc.)
 Data used for more accurate search marketing targeting and other applications.

			
	Bounce Processing ASP	  	Prior to 3/26/2007	  	 Application Service Provider infrastructure to process email bounces on behalf of multiple senders. Includes mechanisms to build
a co-operative database to assist in determining where a bounce may not be a dead address due to other companies’ successful deliveries.
  

Related cooperative database for responsiveness scoring.
  

Related processing of email lists for de-duplication (unsubscribe or other suppression lists.)

			
	B2B Change of Address Detection	  	Prior to 3/26/2007	  	Service to inform businesses that a contact has moved. Data sources for database include: public sources announcing new executive moves, email bounces for information in
email and potentially in combination with phone verification (use marketer and newsletter publisher sources), other data providers (e.g., LinkedIn, Plaxo, ZoomInfo).

 

	 ̈	No inventions or improvements 

  

	 ̈	Additional sheets attached 

  

			
	Date:	 	3/27/07
	Employee Signature:	 	/s/ Edward Henrich
		 	Ed Henrich

  
 9 

 EXHIBIT B 
 CALIFORNIA LABOR CODE SECTION 2870 
 EMPLOYMENT AGREEMENTS; ASSIGNMENT OF
RIGHTS 
 Any provision in an employment agreement which provides that an employee shall assign, or offer to assign, any of his or her
rights in an invention to his or her employer shall not apply to an invention that the employee developed entirely on his or her own time without using the employers equipment, supplies, facilities, or trade secret information except for those
inventions that either: 
 (1) Relate at the time of conception or reduction to practice of the invention to the employer’s business, or
actual or demonstrably anticipated research or development of the employer. 
 (2) Result from any work performed by the employee for the
employer. 
 (a) To the extent a provision in an employment agreement purports to require an employee to assign an invention otherwise excluded
from being required to be assigned under subdivision (a), the provision is against the public policy of this state and is unenforceable.” 

  
 10 

 EXHIBIT C 
 RESPONSYS, INC. TERMINATION CERTIFICATION 
 This is to certify that I do not have in my
possession, nor have I failed to return, any devices, records, data, notes, reports, proposals, lists, correspondence, specifications, drawings, blueprints, sketches, materials, equipment, other documents or property, or reproductions of any
aforementioned items belonging to Responsys, Inc., its subsidiaries, affiliates, successors or assigns (together, the “Company”). 
 I
further certify that I have complied with all the terms of the Company’s Employment Confidential Information and Invention Assignment Agreement signed by me, including the reporting of any inventions and original works of authorship (as defined
therein), conceived or made by me (solely or jointly with others) covered by that agreement. 
 I further agree that, in compliance with the
Employment, Confidential Information and Invention Assignment Agreement, I will preserve as confidential all trade secrets, confidential knowledge, data or other proprietary information relating to products, processes, know-how, designs, formulas,
developmental or experimental work, computer programs, data bases, other original works of authorship, customer lists, business plans, financial information or other subject matter pertaining to any business of the Company or any of its employees,
clients, consultants or licensees. 
 I further agree that for twelve (12) months from this date, I will not solicit, induce, recruit or
encourage any of the Company’s employees to leave their employment. 
  

			
	Date:	 	3/27/07
	Signature:	 	/s/ Edward Henrich
		 	Ed Henrich

  
 11 

 EXHIBIT D 
 RESPONSYS, INC. CONFLICT OF INTEREST GUIDELINES 
 It is the policy of Responsys, Inc. to
conduct its affairs in strict compliance with the letter and spirit of the law and to adhere to the highest principles of business ethics. Accordingly, all officers, employees and independent contractors must avoid activities which are in conflict,
or give the appearance of being in conflict, with these principles and with the interests of the Company. The following are potentially compromising situations which must be avoided. Any exceptions must be reported to the President and written
approval for continuation must be obtained. 
  

	1.	Revealing confidential information to outsiders or misusing confidential information. Unauthorized divulging of information is a violation of this policy whether or not
for personal gain and whether or not harm to the Company is intended. (The Employment, Confidential Information and Invention Assignment Agreement elaborates on this principle and is a binding agreement.) 

 

	2.	Accepting or offering substantial gifts, excessive entertainment, favors or payments which may be deemed to constitute undue influence or otherwise be improper or
embarrassing to the Company. 

  

	3.	Participating in civic or professional organizations that might involve divulging confidential information of the Company. 

 

	4.	Initiating or approving personnel actions affecting reward or punishment of employees or applicants where there is a family relationship or is or appears to be a
personal or social involvement (other than as officers of the Company appointed by the Board of Directors). 

  

	5.	Initiating or approving any form of personal or social harassment of employees. 

 

	6.	Investing or holding outside directorship in suppliers, customers, or competing companies, including financial speculations, where such investment or directorship might
influence in any manner a decision or course of action of the Company. Responsys grants an exception to this rule regarding your continued participation on the Board of Directors for Vertical Response. 

 

	7.	Borrowing from or lending to employees, customers or suppliers. 

  

	8.	Acquiring real estate of interest to the Company. 

  

	9.	Improperly using or disclosing to the Company any proprietary information or trade secrets of any former or concurrent employer or other person or entity with whom
obligations of confidentiality exist. 

  

	10.	Unlawfully discussing prices, costs, customers, sales or markets with competing companies or their employees. 

 

	11.	Making any unlawful agreement with distributors with respect to prices. 

  

	12.	Improperly using or authorizing the use of any inventions which are the subject of patent claims of any other person or entity. 

 

	13.	Engaging in any conduct which is not in the best interest of the Company. 

 Each officer, employee and independent contractor must take every necessary action to ensure compliance with these guidelines and to bring problem areas to the attention of higher management for review.
Violations of this conflict of interest policy may result in discharge without warning. 
 DISCLOSURE AND CONSENT CONCERNING
CONSUMER 
 AND INVESTIGATIVE CONSUMER REPORTS 

  
 12 

 This form, which you should mad carefully, has been provided to you because RESPONSYS INC.
(“Company”) may request Consumer Reports and/or Investigative Consumer Reports from a consumer reporting agency. The Company will use any such
 report(s) solely for employment-related purposes. 

Consumer Reports or Investigative Consumer Reports will be obtained from HireRight, Inc., (“HireRight”) located at 2100 Main Street, Suite 400,
Irvine, CA 92614. They can he contacted at 800- 400-2761. Any such reports may contain information bearing on your character, general reputation, personal characteristics, mode of living and credit standing. The types of information that may be
obtained include, but are not limited to: credit reports, social security number, criminal records checks, public court records checks, including civil, driving records, educational records, verification of employment positions held, workers
compensation records, personal and professional references, licensing, certification, etc. The information contained in these reports may be obtained by HireRight from private or public record sources including sources identified by you in your job
application or through interviews or correspondence with your past or present coworkers, neighbors, friends, associates, current or former employers, educational institutions or other acquaintances. 

For California residents, under section 1786.22 of the California Civil Code, you may view the file maintained on you by HireRight. You may also obtain a
copy of this file, upon submitting proper identification and paying the costs of duplication services, by appearing at HireRight’s offices in person, during normal business hours and on reasonable notice, or by mail; you may also receive a
summary of the file by telephone. HireRight has trained personnel available to explain your file to you, including any coded information. If you appear in person, you may be accompanied by one other person, provided that person furnishes proper
identification. 
 You are being given a copy of the “Summary of Your Rights Under the Fair Credit Reporting Act” prepared pursuant to
15 U.S.C. section 1681(g)(c). You have the right to request additional disclosures of the nature and scope of the investigation and a statement of your rights by contacting HireRight. 

CONSENT 
 I have
carefully read and understand this Disclosure and Consent form and, by my signature below, consent to the release of consumer and/or investigative consumer reports, as defined above, to the Company in conjunction with my application for employment,
I further understand that any and all information contained in my job application or otherwise disclosed to the Company by me before, during or after my employment, if any, may be utilized for the purpose of obtaining the consumer reports or
investigative consumer reports requested by the Company. I understand that if the Company hires me, it 
 may request a consumer report and/or
an investigative consumer report about me, as defined above, for employment-related purposes during the course of my employment. I understand that my consent will 
 apply throughout my employment, to the extent permitted by law, unless I revoke or cancel my consent by sending a signed letter or statement to the Company at any time. This Disclosure and Consent form,
in 

  
 13 

 
original, faxed, photocopied or electronic form, will be valid for any reports that may be requested by the Company. 
 Applicant Last Name         Henrich                  First
        Edward          Middle         Allen        

 Social Security
#     [omitted]                                 Date of
Birth (for ID purposes only)     [omitted]     
 Drivers License
#     [omitted]                             Phone
Number     [omitted]                                 
                
 Present
Address     [omitted]                                 
                                         
                                       

City/State/Zip     [omitted]                
                                         
                                         
           
 Applicant Signature /s/ Edward
Henrich                                       
                                         
         
 CALIFORNIA, MINNESOTA AND OKLAHOMA APPLICANTS ONLY: 

 

	x	I wish to receive a free copy of any Consumer Report and/or Investigative Consumer Report on me that is requested. 

  
 14 

 EXHIBIT E 
 Companies Qualifying for Referral Bonus 
 Hewlett-Packard Company (NYSE:HPQ) 

Expedia, Inc. (NASD:EPE) 
 Federated Department
Stores, Inc. (NYSE:FD) 
 eBay Inc. (NASD:EBAY) 
 Jones Apparel Group, Inc. (NYSE:JNY) 
 Avon Products, Inc. (NYSE:AVP) 

Texas Instruments Incorporated (NYSE:TXN) 

Barclays Global Investors 
 The Charles Schwab
Corporation (NASD:SCHW) (Excluding EMarketing Group) 
 Valassis Communications, Inc. (NYSE: VCI) 

Yahoo! Inc. (NASD: YHOO) 

 EXHIBIT F 
 Payment of the “Annual Target Bonus in the amount of $50,000” will be based as follows: 
 For the balance of H1, ending June 30, 2007 you are eligible for a bonus of $12,500 based on objectives that will be assigned to you shortly after your start date. 

For H2, ending December 31, 2007, you are eligible for a bonus of $10,000 based on objectives that will be assigned to you shortly
after your start date. You are also eligible for an additional bonus of $15,000 based on achievement of $7.5 Million in Services Revenue. 

Payment of the “Stretch Bonus in the amount of $50,000” will be based as follows: 

For H2, beginning July 1, 2007 and ending December 31, 2007, you are eligible for a bonus equal to 10% of Services Revenue in
excess of $4.5 Million. 
 Note: All Loyalty Matrix revenues attributable to Loyalty Matrix customers are excluded from the above formulas.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00184-of-00352.parquet"}]]